Antiviral antibodies are necessary for control of simian immunodeficiency virus replication

Chris J Miller, Meritxell Genescà, Kristina Abel, David Montefiori, Donald Forthal, Kristen Bost, Jun Li, David Favre, Joseph M. McCune

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

To better define the role of B cells in the control of pathogenic simian immunodeficiency virus (SIV) replication, six rhesns monkeys were depleted of B cells by intravenous infusion of rifaximato (anti-CD20) 28 days and 7 days before intravaginal SFVmac239 inoculation and every 21 days thereafter until AIDS developed. Although the blood and tissues were similarly depleted of B cells, anti-SIV immunoglobulin G (IgG) antibody responses were completely blocked in only three of the six animals. In all six animals, levels of viral RNA (vRNA) in plasma peaked at 2 weeks and declined by 4 weeks postinoculation (PI). However, the three animals prevented from making an anti-SIV antibody response had significantly higher plasma vRNA levels through 12 weeks PI (P = 0.012). The remaining three B-cell-depleted animals made moderate anti-SIV IgG antibody responses, maintained moderate plasma SIV loads, and showed an expected rate of disease progression, surviving to 24 weeks PI without developing AIDS. In contrast, all three of the B-cell-depleted animals prevented from making anti-SIV IgG responses developed AIDS by 16 weeks PI (P = 0.0001). These observations indicate that antiviral antibody responses are critical in maintaining effective control of SIV replication at early time points postinfection.

Original languageEnglish (US)
Pages (from-to)5024-5035
Number of pages12
JournalJournal of Virology
Volume81
Issue number10
DOIs
StatePublished - May 2007

Fingerprint

Simian immunodeficiency virus
Simian Immunodeficiency Virus
Virus Replication
virus replication
Antiviral Agents
B-lymphocytes
antibodies
Antibodies
B-Lymphocytes
Antibody Formation
immunoglobulin G
Acquired Immunodeficiency Syndrome
Immunoglobulin G
Viral RNA
animals
RNA
viral load
disease course
Intravenous Infusions
Haplorhini

ASJC Scopus subject areas

  • Immunology

Cite this

Miller, C. J., Genescà, M., Abel, K., Montefiori, D., Forthal, D., Bost, K., ... McCune, J. M. (2007). Antiviral antibodies are necessary for control of simian immunodeficiency virus replication. Journal of Virology, 81(10), 5024-5035. https://doi.org/10.1128/JVI.02444-06

Antiviral antibodies are necessary for control of simian immunodeficiency virus replication. / Miller, Chris J; Genescà, Meritxell; Abel, Kristina; Montefiori, David; Forthal, Donald; Bost, Kristen; Li, Jun; Favre, David; McCune, Joseph M.

In: Journal of Virology, Vol. 81, No. 10, 05.2007, p. 5024-5035.

Research output: Contribution to journalArticle

Miller, CJ, Genescà, M, Abel, K, Montefiori, D, Forthal, D, Bost, K, Li, J, Favre, D & McCune, JM 2007, 'Antiviral antibodies are necessary for control of simian immunodeficiency virus replication', Journal of Virology, vol. 81, no. 10, pp. 5024-5035. https://doi.org/10.1128/JVI.02444-06
Miller, Chris J ; Genescà, Meritxell ; Abel, Kristina ; Montefiori, David ; Forthal, Donald ; Bost, Kristen ; Li, Jun ; Favre, David ; McCune, Joseph M. / Antiviral antibodies are necessary for control of simian immunodeficiency virus replication. In: Journal of Virology. 2007 ; Vol. 81, No. 10. pp. 5024-5035.
@article{5e24b54343c64ffdab5252df7637c5ce,
title = "Antiviral antibodies are necessary for control of simian immunodeficiency virus replication",
abstract = "To better define the role of B cells in the control of pathogenic simian immunodeficiency virus (SIV) replication, six rhesns monkeys were depleted of B cells by intravenous infusion of rifaximato (anti-CD20) 28 days and 7 days before intravaginal SFVmac239 inoculation and every 21 days thereafter until AIDS developed. Although the blood and tissues were similarly depleted of B cells, anti-SIV immunoglobulin G (IgG) antibody responses were completely blocked in only three of the six animals. In all six animals, levels of viral RNA (vRNA) in plasma peaked at 2 weeks and declined by 4 weeks postinoculation (PI). However, the three animals prevented from making an anti-SIV antibody response had significantly higher plasma vRNA levels through 12 weeks PI (P = 0.012). The remaining three B-cell-depleted animals made moderate anti-SIV IgG antibody responses, maintained moderate plasma SIV loads, and showed an expected rate of disease progression, surviving to 24 weeks PI without developing AIDS. In contrast, all three of the B-cell-depleted animals prevented from making anti-SIV IgG responses developed AIDS by 16 weeks PI (P = 0.0001). These observations indicate that antiviral antibody responses are critical in maintaining effective control of SIV replication at early time points postinfection.",
author = "Miller, {Chris J} and Meritxell Genesc{\`a} and Kristina Abel and David Montefiori and Donald Forthal and Kristen Bost and Jun Li and David Favre and McCune, {Joseph M.}",
year = "2007",
month = "5",
doi = "10.1128/JVI.02444-06",
language = "English (US)",
volume = "81",
pages = "5024--5035",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Antiviral antibodies are necessary for control of simian immunodeficiency virus replication

AU - Miller, Chris J

AU - Genescà, Meritxell

AU - Abel, Kristina

AU - Montefiori, David

AU - Forthal, Donald

AU - Bost, Kristen

AU - Li, Jun

AU - Favre, David

AU - McCune, Joseph M.

PY - 2007/5

Y1 - 2007/5

N2 - To better define the role of B cells in the control of pathogenic simian immunodeficiency virus (SIV) replication, six rhesns monkeys were depleted of B cells by intravenous infusion of rifaximato (anti-CD20) 28 days and 7 days before intravaginal SFVmac239 inoculation and every 21 days thereafter until AIDS developed. Although the blood and tissues were similarly depleted of B cells, anti-SIV immunoglobulin G (IgG) antibody responses were completely blocked in only three of the six animals. In all six animals, levels of viral RNA (vRNA) in plasma peaked at 2 weeks and declined by 4 weeks postinoculation (PI). However, the three animals prevented from making an anti-SIV antibody response had significantly higher plasma vRNA levels through 12 weeks PI (P = 0.012). The remaining three B-cell-depleted animals made moderate anti-SIV IgG antibody responses, maintained moderate plasma SIV loads, and showed an expected rate of disease progression, surviving to 24 weeks PI without developing AIDS. In contrast, all three of the B-cell-depleted animals prevented from making anti-SIV IgG responses developed AIDS by 16 weeks PI (P = 0.0001). These observations indicate that antiviral antibody responses are critical in maintaining effective control of SIV replication at early time points postinfection.

AB - To better define the role of B cells in the control of pathogenic simian immunodeficiency virus (SIV) replication, six rhesns monkeys were depleted of B cells by intravenous infusion of rifaximato (anti-CD20) 28 days and 7 days before intravaginal SFVmac239 inoculation and every 21 days thereafter until AIDS developed. Although the blood and tissues were similarly depleted of B cells, anti-SIV immunoglobulin G (IgG) antibody responses were completely blocked in only three of the six animals. In all six animals, levels of viral RNA (vRNA) in plasma peaked at 2 weeks and declined by 4 weeks postinoculation (PI). However, the three animals prevented from making an anti-SIV antibody response had significantly higher plasma vRNA levels through 12 weeks PI (P = 0.012). The remaining three B-cell-depleted animals made moderate anti-SIV IgG antibody responses, maintained moderate plasma SIV loads, and showed an expected rate of disease progression, surviving to 24 weeks PI without developing AIDS. In contrast, all three of the B-cell-depleted animals prevented from making anti-SIV IgG responses developed AIDS by 16 weeks PI (P = 0.0001). These observations indicate that antiviral antibody responses are critical in maintaining effective control of SIV replication at early time points postinfection.

UR - http://www.scopus.com/inward/record.url?scp=34248370960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248370960&partnerID=8YFLogxK

U2 - 10.1128/JVI.02444-06

DO - 10.1128/JVI.02444-06

M3 - Article

C2 - 17329327

AN - SCOPUS:34248370960

VL - 81

SP - 5024

EP - 5035

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 10

ER -